HDAC6 and Miyoshi myopathy: Recently, Garcia-Guerrero et al. demonstrated that the specific inhibitor of the histone deacetylase 6 (HDAC6), ricolinostat, also increases CD38 RNA expression levels and CD38 molecules on the surface of MM cells.